Aperture Venture Partners

Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.

Business Model:

Revenue: $6.4M

Employees: 2-10

Rankings

Detailed Aperture Venture Partners Information

Geographic Data

Aperture Venture Partners headquarters map

Address: 645 Madison Ave

City: New York

State: NY

Zip: 10022

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$49M

Metrics

7,485,949Website Global Rank

525Website Monthly Traffic

Twitter Followers

Description

Aperture Venture Partners is a venture capital group committed to working with exceptional entrepreneurs to tackle significant problems and create major new opportunities. They work with companies across a variety of sectors, primarily within the healthcare and healthy living industries. Their initial investment size ranges between $1 million and $5 million and they invest nationally. Their principals have been entrepreneurial leaders in the healthcare and investment industries over the past 30 years. They have successfully invested more than $1 billion and founded companies that have had combined revenues greater than $1 billion.

Contact Phone:
+12127587325

Contact Email:

Announced Date Company Transaction Money Raised
12/2005 Altea Therapeutics Series C 32.8M
2/1992 Metra Biosystems Venture Round 0
6/2021 Cortica Series C 60M
2/2007 MAKO Surgical Series C 0
12/2021 PetDx Series B 62M
10/2019 ShiraTronics Series A 0
1/2020 Tarsus Pharmaceuticals Series B 60M
8/2011 Ceptaris Therapeutics Series D 14.4M
6/2012 Ceptaris Therapeutics Series D 10M
3/2023 Shoulder Innovations Series D 0
9/2015 Aclaris Therapeutics Series C 40M
1/2020 Cortica Venture Round -
11/2018 Cortica Venture Round -
1/2021 Neuros Medical Series B 0
7/2017 Trevi Therapeutics Series C 30M
5/2013 Channel Medsystems Series B 9.8M
4/2015 Spirox Series B 18.5M
5/2010 CardioMEMS Venture Round 0
10/2009 CardioMEMS Series F 0
3/2004 TransMolecular Series C 0
8/2017 Neuros Medical Series A 20M
3/2016 Spirox Series C 45M
3/2014 Axonics Modulation Technologies Series A 32.6M
4/2023 Cortica Series D 0
8/2017 Channel Medsystems Series C 0
9/2013 Otonomy Series C 45.9M
7/2005 Altea Therapeutics Series C 30M
2/2015 Lyricpharma Series A 20.4M
12/2013 Xlumena Series C 0
4/2011 Xlumena Series B 0
2/2017 Bristol Myers Squibb Post-IPO Equity 80M
10/2019 Verix Health Series A 0
2/2022 Nalu Medical Venture Round 0
7/2004 Nina McLemore Venture Round 3.7M
11/2003 Redpoint Bio Series A 0
3/2015 Cardiac Dimensions Equity 15.2M
9/2018 Endotronix Series D 0
1/2007 Ception Therapeutics Series C 63M
9/2020 Cardiac Dimensions Series C 17.5M
5/2022 XII Medical Series A 0
7/2016 Endotronix Series C 0
7/2009 Interlace Medical Series C 20.5M
8/2005 MAKO Surgical Series B 0
3/2015 Collegium Pharmaceutical Private Equity Round 0
5/2014 Inspire Medical Systems Series E 0
7/2005 TherOx Venture Round 30M
4/2018 V-Wave Series C 0
9/2015 Channel Medsystems Series C 0
7/2011 Avedro Series C 0
3/2013 Avedro Series D 0
9/2020 V-Wave Series C 0
4/2018 Cardiac Dimensions Series B 39M
4/2019 Bardy Diagnostics Series B 35.5M
5/2022 XII Medical Series A 0
2/2022 Nalu Medical Venture Round 0
12/2021 PetDx Series B 0
6/2021 Cortica Series C 0
1/2021 Neuros Medical Series B 0
9/2020 Cardiac Dimensions Series C 0
9/2020 V-Wave Series C 0
1/2020 Cortica Venture Round -
1/2020 Tarsus Pharmaceuticals Series B 0
10/2019 ShiraTronics Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research